FDA approves 1st self-administered flu vaccine
FDA approves first flu vaccine that can be self-administered at home
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.
FDA Approves First Self-Administered Nasal Spray Flu Vaccine
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered flu vaccine option.
FDA approves FluMist for self-administration
The FluMist vaccine can now be self-administered after the FDA approved its use to treat the influenza disease.
FDA approves first nasal spray flu vaccine for use at home
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before expanding eligibility in 2007 to children as young as 2 years old — requiring in both instances that it be administered by a vaccine provider.
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
At-home nasal spray flu vaccine coming next year
A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and Drug Administration expanded its approval of AstraZeneca's FluMist. Why it matters: It will be the first flu vaccine that doesn't need to be administered by a health provider and will be sold direct to consumers for home use via an online pharmacy.
At-home flu vaccine authorized by FDA
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be prescribed before purchase.
EBGLYSS for eczema: What to know about the newly FDA-approved drug from Eli Lilly
The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...
FiercePharma7h
UCB rapidly bolsters blockbuster potential for Bimzelx with 3 new FDA approvals
Less than a year after snagging its first FDA approval in psoriasis, UCB’s blockbuster hopeful Bimzelx has picked up three ...
ConsumerAffairs3h
FDA finds that some 'dairy-free' chocolates aren’t
When is “dairy-free” actually dairy-free? If you’re one of the nearly 30 million American adults who have some degree of ...
STAT11h
Millions of Americans want to quit smoking. Critics say drugmakers and the FDA are failing them
There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...
dvm3603h
FDA announces Smiths Medical ventilator recall
The FDA's Center for Veterinary Medicine (CVM) announced Smiths Medical’s recall of the PneuPAC paraPAC Plus P300 and ...
Nationwide Snack Recall Update As FDA Sets Highest Risk Level
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
Medscape19h
FDA Clears AI-Powered Thyroid Ultrasound Analysis System
The US Food and Drug Administration (FDA) has issued 510(k) clearance to See-Mode Technologies for their AI-based thyroid ...